Yahoo Finance

neurocare group's Apollo TMS Therapy Devices Now Have FDA Clearance to Treat Adolescents Suffering With Major Depression

A young man receiving Apollo TMS Therapy by neurocare — a non-invasive, FDA-cleared treatment offering new hope for adolescents living with depression · GlobeNewswire Inc. Munich, Germany; Atlanta, ...
Yahoo Finance

NRx Pharmaceuticals (Nasdaq:NRXP) and neurocare Group AG Announce Joint Offering of Neuroplastic Therapy Targeting Depression, PTSD, and other mental health afflictions

Program will integrate existing neurocare clinics with HOPE Therapeutics clinics and will engage the already-installed base of 400+ Apollo ® Transcranial Magnetic Stimulation (TMS) machines nationwide ...
PharmiWeb

Neurocare Group Receives FDA Clearance for Its Industry-Leading Intermittent Theta Burst Stimulation (iTBS) Protocol for Transcranial Magnetic Stimulation (TMS)

neurocare is pleased to announce that it has received FDA clearance for its industry-leading intermittent Theta Burst Stimulation (iTBS) protocol, available across its Apollo TMS Therapy System and ...
PharmiWeb

Neurocare Group Receives FDA Clearance for Treatment of OCD With Its Transcranial Magnetic Stimulation (TMS) Devices

neurocare's Apollo TMS Therapy systems are now FDA-cleared for the treatment of Obsessive Compulsive Disorder, offering a new non-drug treatment option for patients and providers. MUNICH, GERMANY AND ...
Finanznachrichten

NRx Pharmaceuticals, Inc.: NRx Pharmaceuticals (Nasdaq:NRXP) and neurocare Group AG Announce Joint Offering of Neuroplastic Therapy Targeting Depression, PTSD, and other mental ...

Program will integrate existing neurocare clinics with HOPE Therapeutics clinics and will engage the already-installed base of 400+ Apollo - Transcranial Magnetic Stimulation (TMS) machines nationwide ...